Pyrazinamide and Viread drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pyrazinamide (pyrazinamide) and Viread (tenofovir disoproxil fumarate). Common drug interactions include drug level increased among females and renal failure among males.

The phase IV clinical study analyzes what interactions people have when they take Pyrazinamide and Viread. It is created by eHealthMe based on reports of 40 people who take the same drugs from the FDA, and is updated regularly.

What is Pyrazinamide?

Pyrazinamide has active ingredients of pyrazinamide. It is often used in tuberculosis. eHealthMe is studying from 10,062 Pyrazinamide users. Check the latest studies of Pyrazinamide.

What is Viread?

Viread has active ingredients of tenofovir disoproxil fumarate. It is often used in hepatitis b. eHealthMe is studying from 51,542 Viread users. Check the latest studies of Viread.



On Jul, 12, 2026

40 people who take Pyrazinamide and Viread together, and have interactions are studied.

Pyrazinamide and Viread drug interactions.

What are the common drug interactions of Pyrazinamide and Viread, by gender? *:

female:

  1. Drug level increased
  2. Nausea (feeling of having an urge to vomit)
  3. Pulmonary tuberculosis (lungs tuberculosis)
  4. Sleep disorder
  5. Transaminases increased
  6. Vomiting
  7. Depression
  8. Hepatic failure (liver failure)
  9. Herpes virus infection
  10. Hypophagia (reduced food intake)

male:

  1. Renal failure (kidney dysfunction)
  2. Anaemia (lack of blood)
  3. Drug eruption (adverse drug reaction of the skin)
  4. Emotional distress
  5. Hepatotoxicity (chemical-driven liver damage)
  6. Hyperuricaemia (level of uric acid in the blood that is abnormally high)
  7. Leukopenia (less number of white blood cells in blood)
  8. Nephropathy (damage to or disease of a kidney)
  9. Pain
  10. Pyrexia (fever)

What are the common drug interactions of Pyrazinamide and Viread, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Nausea (feeling of having an urge to vomit)
  2. Platelet count decreased
  3. Drug level increased
  4. Pulmonary tuberculosis (lungs tuberculosis)
  5. Sleep disorder
  6. Transaminases increased
  7. Vomiting
  8. Alanine aminotransferase increased
  9. Aspartate aminotransferase increased
  10. Pyrexia (fever)

30-39:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Anaemia (lack of blood)
  3. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  4. Coma (state of unconsciousness lasting more than six hours)
  5. Hepatotoxicity (chemical-driven liver damage)
  6. Hyperuricaemia (level of uric acid in the blood that is abnormally high)
  7. Immune reconstitution syndrome (immune recovery syndrome)
  8. Renal failure acute (rapid kidney dysfunction)
  9. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  10. Depression

40-49:

  1. Chronic kidney disease
  2. Emotional distress
  3. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  4. Hepatic failure (liver failure)
  5. Multiple fractures
  6. Nephropathy (damage to or disease of a kidney)
  7. Pain
  8. Renal atrophy (wasting of kidney)
  9. Renal failure (kidney dysfunction)
  10. Rib fracture

50-59:

  1. Drug eruption (adverse drug reaction of the skin)
  2. Leukopenia (less number of white blood cells in blood)
  3. Anaemia (lack of blood)
  4. Aspartate aminotransferase increased
  5. Ataxia (loss of full control of bodily movements)
  6. Brain abscess
  7. Confusional state
  8. Death
  9. Depressed level of consciousness
  10. Disseminated tuberculosis

60+:

  1. Abdominal pain upper
  2. Asthenia (weakness)
  3. Renal failure (kidney dysfunction)
  4. Atrioventricular block complete (heart block complete)
  5. Blood potassium increased
  6. Bradycardia (abnormally slow heart action)
  7. Dehydration (dryness resulting from the removal of water)
  8. Diarrhoea
  9. Dizziness
  10. Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

  1. Hiv Infection: 29 people, 72.50%
  2. Pulmonary Tuberculosis (lungs tuberculosis): 6 people, 15.00%
  3. Anaemia (lack of blood): 6 people, 15.00%
  4. Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 5 people, 12.50%
  5. Sinusitis (inflammation of sinus): 3 people, 7.50%
  6. Pain: 2 people, 5.00%
  7. Leukopenia (less number of white blood cells in blood): 2 people, 5.00%
  8. Kaposi's Sarcoma Aids Related (a tumour caused by human herpes virus associated with aids): 2 people, 5.00%
  9. Bladder Outlet Obstruction (urological condition where the urine flow from the urinary bladder through the urethra is impeded): 2 people, 5.00%
  10. Acarodermatitis (skin inflammation caused by mites (acarids)): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pyrazinamide and Viread?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pyrazinamide and Viread:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pyrazinamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Viread:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pyrazinamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Viread and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pyrazinamide and tenofovir disoproxil fumarate (the active ingredients of Pyrazinamide and Viread, respectively), and Pyrazinamide and Viread (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: